POST-COVID SYNDROME IN CHILDREN – THE INVISIBLE CONSEQUENCE OF A VISIBLE DISEASE
DOI:
https://doi.org/10.55640/Keywords:
Post-COVID syndrome, Long COVID, children, pediatrics, adolescents, COVID-19 consequences, post-viral asthenia, brain fog, diagnosis, rehabilitation, multisystem inflammatory syndrome (MIS-C).Abstract
It was believed that COVID-19 spared the pediatric population, presenting in mild or asymptomatic forms. However, months after the pandemic, the medical community encountered a new challenge, post-COVID syndrome (Long COVID) in children and adolescents. This article provides a detailed overview of the symptoms, pathogenesis, diagnosis, and treatment approaches for this prolonged condition, aiming to raise awareness among pediatricians, parents, and educators. Based on an analysis of current literature, the paper emphasizes the multifaceted nature of the clinical presentation and the need for an interdisciplinary approach to rehabilitation.
Downloads
References
1. World Health Organization (WHO). A clinical case definition of post COVID-19 condition by a Delphi consensus. 2021.
2. Stephenson, T., et al. (2022). Long COVID and the mental and physical health of children and young people: national matched cohort study protocol (the CLoCk study). BMJ Open, 12(7), e065276.
3. Buonsenso, D., et al. (2022). Clinical characteristics, activity levels and mental health problems in children with long COVID: a survey of 510 children. Frontiers in Pediatrics, 9, 834160.
4. Zavala, M., et al. (2023). Cognitive Impairment in Long COVID in Children: A Multidisciplinary Approach. Journal of Clinical Medicine, 12(5), 1803.
5. Feldstein, L. R., et al. (2021). Multisystem Inflammatory Syndrome in U.S. Children and Adolescents. New England Journal of Medicine, 385(4), 334-346.
6. Proal, A. D., & VanElzakker, M. B. (2021). Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Frontiers in Microbiology, 12, 698169.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

Germany
United States of America
Italy
United Kingdom
France
Canada
Uzbekistan
Japan
Republic of Korea
Australia
Spain
Switzerland
Sweden
Netherlands
China
India